PVCT
Provectus Biopharmaceuticals Inc.

1,944
Mkt Cap
$27.32M
Volume
110,860.00
52W High
$0.1349
52W Low
$0.05
PE Ratio
-4.11
PVCT Fundamentals
Price
$0.0656
Prev Close
$0.065
Open
$0.0653
50D MA
$0.0702
Beta
0.19
Avg. Volume
327,222.11
EPS (Annual)
-$0.0113
P/B
-4.43
Rev/Employee
$102,856.67
Loading...
Loading...
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6

Frequently Asked Questions

What is Market Cap of Provectus Biopharmaceuticals Inc?
What is the 52-week high for Provectus Biopharmaceuticals Inc?
What is the 52-week low for Provectus Biopharmaceuticals Inc?
What is Provectus Biopharmaceuticals Inc stock price today?
What was Provectus Biopharmaceuticals Inc stock price yesterday?
What is the PE ratio of Provectus Biopharmaceuticals Inc?
What is the Price-to-Book ratio of Provectus Biopharmaceuticals Inc?
What is the 50-day moving average of Provectus Biopharmaceuticals Inc?
How many employess does Provectus Biopharmaceuticals Inc has?

Latest PVCT News

View
No PVCT news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.